Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)
Digital Health Global
APRIL 10, 2023
–(BUSINESS WIRE)– Aviceda Therapeutics , a clinical-stage biotech company focused on developing next-generation immuno-modulators to treat diseases such as cancer, today announced a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (Queen’s). CAMBRIDGE, Mass.–(BUSINESS
Let's personalize your content